Location: The Heritage Foundation's Allison Auditorium
Federal preemption of state law raises important questions
concerning both protecting American consumers and our
economy. Is federal preemption an obstacle to protecting
Americans from being injured by harmful products or is it necessary
to prevent patchwork "regulation by litigation" from stifling
innovation and new product development, such as life-sustaining
drugs? The Supreme Court has provided mixed guidance of late,
denying federal preemption in drug manufacturing yet protecting it
in the manufacture of medical devices. When is federal
preemption appropriate and what factors should Congress consider
when deciding whether federal laws should override state
regulation? The answers to these questions are vital to the
safety and economic well-being of our nation and its
citizens.
More About the Speakers
Sheldon T. Bradshaw
Co-Chair,
Food and Drug Practice Group,
Hunton & Williams LLP,
and former Chief Counsel,
U.S. Food and Drug Administration
Ted Frank
Resident Fellow,
American Enterprise Institute,
and Founder,
Center for Class Action Fairness
Jeff A. Rosen
Senior Partner,
Kirkland & Ellis LLP,
and former General Counsel,
White House Office of Management and Budget and U.S. Department of
Transportation
Hosted By
Hans von Spakovsky
Senior Legal Fellow / Manager, Civil Justice Reform Initiative
Read More